AI aims to speed up brain scan reports for urgent cases

NCT ID NCT07671664

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests an AI tool called MIDI that quickly spots problems in brain MRI scans. The goal is to see if it helps doctors report urgent scans faster, so patients get treatment sooner. Over 100,000 adults will take part across multiple NHS sites in the UK.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

MIDI, an AI-based triage tool for brain MRI scans

What this could lead to

If successful, this could show that AI can help doctors prioritize urgent brain scans, leading to faster diagnoses and treatment for patients.

What could go wrong

This is a large trial but still early in real-world testing. The AI may not always work as expected, and its impact on patient outcomes is not yet proven.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic malignant neoplasm in the brain stroke disorder transient ischemic attack

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••